Published online before print December 30, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
*Medical Clinic II and Department of Dermatology, University of Erlangen-Nuremberg, Germany
@ To whom correspondence should be addressed. E-mail: A.Yilmaz.med2.uni-erlangen{at}email.de.
Statins were shown to possess immunomodulating properties, but the mechanisms of statin effects on the immune system are poorly understood. We analyzed the influence of statins on professional antigen-presenting dendritic cells (DC). Immature DC were cultivated from monocytes of healthy donors. DC maturation was induced by lipopolysaccharide (LPS; 1 µg/mL). Unstimulated and LPS-stimulated DC were treated with simvastatin or atorvastatin (0.1-1 µM). The expression of CD40, CD83, CD86, and human leukocyte antigen-DR on unstimulated and LPS-stimulated DC was reduced significantly by statins, and the expression of Toll-like receptor 2 (TLR2) and TLR4 on LPS-stimulated DC was enhanced temporarily. Statins caused a significant reduction of endocytosis of fluorescein isothiocyanate-dextran by DC. Statins significantly inhibited the basal secretion of interleukin (IL)-6, IL-8, IL-12, and tumor necrosis factor 
from unstimulated DC, and their release from LPS-stimulated DC was enhanced. In mixed leukocyte reaction, preincubation of LPS-stimulated DC with statins significantly suppressed their clustering with T cells and their ability to induce T cell proliferation, CD71, and CD25 up-regulation on T cells and the secretion of interferon-
and IL-2 from T cells. In conclusion, this study showed that statins suppressed endocytosis, basal secretion of proinflammatory cytokines, and the ability of DC to induce T cell proliferation, activation, and T helper cell type 1 differentiation. However, statin preincubation of LPS-stimulated DC caused a further increase in their secretion of proinflammatory cytokines.
Key Words: atherosclerosis • inflammation • immunity
This article has been cited by other articles:
 |
|
 |
|
  D. Benati, M. Ferro, M. T. Savino, C. Ulivieri, E. Schiavo, A. Nuccitelli, F. L. Pasini, and C. T. Baldari Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus J. Leukoc. Biol., March 1, 2010; 87(3): 433 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Helmers, D. C. Gowda, K. C. Kain, and W. C. Liles Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages Am J Trop Med Hyg, October 1, 2009; 81(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montecucco, F. Burger, G. Pelli, N. K. Poku, C. Berlier, S. Steffens, and F. Mach Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes Rheumatology, March 1, 2009; 48(3): 233 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Imamura, K Okunishi, H Ohtsu, K Nakagome, H Harada, R Tanaka, K Yamamoto, and M Dohi Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung Thorax, January 1, 2009; 64(1): 44 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mira, B. Leon, D. F. Barber, S. Jimenez-Baranda, I. Goya, L. Almonacid, G. Marquez, A. Zaballos, C. Martinez-A., J. V. Stein, et al. Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway J. Immunol., September 1, 2008; 181(5): 3524 - 3534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shimabukuro-Vornhagen, T. Liebig, and M. von Bergwelt-Baildon Statins inhibit human APC function: implications for the treatment of GVHD Blood, August 15, 2008; 112(4): 1544 - 1545. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lee, H. Qin, and E. N. Benveniste Simvastatin inhibits IFN-{gamma}-induced CD40 gene expression by suppressing STAT-1{alpha} J. Leukoc. Biol., August 1, 2007; 82(2): 436 - 447. [Abstract] [Full Text] [PDF]
|
|
